首页> 中文期刊>承德医学院学报 >山楂叶总黄酮联合西药治疗急性脑卒中临床疗效观察

山楂叶总黄酮联合西药治疗急性脑卒中临床疗效观察

     

摘要

Objective:To observe the effects of Hawthorn Leaves Flavonoids combined western medicine for treating acute stroke.Methods: 84 acute stroke patients were randomly divided into control group and treatment group with 42 patients in each group. The patients in control group were treated with conventional western medicine; moreover, the patients in treatment group also orally taken Hawthorn Leaves Flavonoids (90mg/time, 3 times/d). The neurological deifcit scores and therapeutic effects of these 2 groups were observed after 2 courses of treatment (28d).Results:After treatment, the neurological deifcit scores of patients in 2 groups were all obviously lower than that before treatment (P<0.05); Moreover, the neurological deifcit scores of patients in treatment group were obviously lower than that in control group after treatment (P<0.05). The total therapeutic effects of treatment group was 95.24% (40/42), which was obviously higher than that of control group after treatment (P<0.05).Conclusions:For treating acute stroke, the therapeutic effects of Hawthorn Leaves Flavonoids combined western medicine is better than pure western medicine.%目的:观察山楂叶总黄酮联合西药治疗急性期脑卒中的疗效。方法:84例急性脑卒中患者随机分为对照组和治疗组,每组42例患者。对照组给予常规西药治疗,治疗组在对照组的基础上加用山楂叶总黄酮口服(90mg/次,3次/d)。两组均治疗2个疗程(28d)后,观察神经功能缺损评分和疗效。结果:治疗后治疗组、对照组患者的神经功能缺损评分均明显低于治疗前(P<0.05);且治疗组患者治疗后的神经功能缺损评分明显低于对照组治疗后(P<0.05)。治疗组的总有效率为95.24%(40/42),明显高于对照组,差别具有统计学意义(P<0.05)。结论:山楂叶总黄酮联合西药治疗急性脑卒中的疗效优于单纯西药治疗。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号